Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$226,761
-$82,399 QoQ
Shares Held
9,417
-14.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#2,361
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUARDIAN INVESTMENT MANAGEMENT holds $13,312,413 across 7 Drug Manufacturers - General names. PFE ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,205 | $5,868,154 | |
| 2 | ABBV |
AbbVie Inc.
|
12,425 | $3,126,627 | |
| 3 | JNJ |
Johnson & Johnson
|
7,907 | $2,008,140 | |
| 4 | BIIB |
Biogen Inc.
|
5,500 | $1,188,330 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,750 | $473,775 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,300 | $420,626 | |
| 7 | PFE |
Pfizer Inc
This page
|
9,417 | $226,761 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,761 | 9,417 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $309,160 | 11,010 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $282,864 | 11,360 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $364,618 | 14,310 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $333,348 | 13,752 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $297,795 | 11,752 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $438,859 | 16,542 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $588,986 | 20,352 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $632,403 | 22,602 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $768,675 | 27,700 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,508,596 | 52,400 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,970,463 | 59,405 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,233,995 | 60,905 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $3,325,648 | 81,511 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,229,657 | 63,030 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,758,192 | 63,030 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $3,902,364 | 74,430 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $3,850,652 | 74,380 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $4,513,191 | 76,430 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $3,270,050 | 76,030 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $3,198,001 | 81,665 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $2,953,143 | 81,511 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,761,154 | 75,011 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,701,521 | 73,611 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,390,732 | 73,111 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $2,329,219 | 71,361 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||